148 related articles for article (PubMed ID: 26538741)
1. Livedoid Vasculopathy with Hyperhomocysteinemia Responding to Hyperbaric Oxygen Therapy.
Ray R; Sharma A; Vasudevan B; Sridhar J; Deo R; Mohanty CS
Indian J Dermatol; 2015; 60(5):524. PubMed ID: 26538741
[TBL] [Abstract][Full Text] [Related]
2. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
[TBL] [Abstract][Full Text] [Related]
3. Dermoscopic features of livedoid vasculopathy.
Hu SC; Chen GS; Lin CL; Cheng YC; Lin YS
Medicine (Baltimore); 2017 Mar; 96(11):e6284. PubMed ID: 28296736
[TBL] [Abstract][Full Text] [Related]
4. Livedoid vasculopathy successfully treated with hyperbaric oxygen.
Banham ND
Diving Hyperb Med; 2013 Mar; 43(1):35-6. PubMed ID: 23508660
[TBL] [Abstract][Full Text] [Related]
5. Livedoid vasculopathy managed with hyperbaric oxygen therapy.
Bhutani S; Verma R; Verghese G
Med J Armed Forces India; 2012 Oct; 68(4):389-91. PubMed ID: 24532913
[TBL] [Abstract][Full Text] [Related]
6. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
Browning CE; Callen JP
Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
[TBL] [Abstract][Full Text] [Related]
7. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
[TBL] [Abstract][Full Text] [Related]
8. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC
Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971
[TBL] [Abstract][Full Text] [Related]
9. Medium-pressure hyperbaric oxygen therapy for livedoid vasculopathy.
Herrera-Sánchez A; Madriagal-Alvarado MJ; Moncayo G; Verdini F
Medicina (B Aires); 2022; 82(4):613-616. PubMed ID: 35904919
[TBL] [Abstract][Full Text] [Related]
10. A Refractory Livedoid Vasculopathy Accompanied by Methylene Tetrahydrofolate Reductase Gene Polymorphism Successfully Treated with Hyperbaric Oxygen Therapy.
Lee SH; Lee Y; Choi EH
Ann Dermatol; 2023 May; 35(Suppl 1):S59-S62. PubMed ID: 37853867
[TBL] [Abstract][Full Text] [Related]
11. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences.
Meiss F; Marsch WC; Fischer M
Eur J Dermatol; 2006; 16(2):159-62. PubMed ID: 16581568
[TBL] [Abstract][Full Text] [Related]
12. Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen.
Yang CH; Ho HC; Chan YS; Liou LB; Hong HS; Yang LC
Br J Dermatol; 2003 Sep; 149(3):647-52. PubMed ID: 14511004
[TBL] [Abstract][Full Text] [Related]
13. Livedoid vasculopathy associated with heterozygous protein C deficiency.
Boyvat A; Kundakçi N; Babikir MO; Gürgey E
Br J Dermatol; 2000 Oct; 143(4):840-2. PubMed ID: 11069468
[TBL] [Abstract][Full Text] [Related]
14. Livedoid vasculopathy: fast involution after anticoagulant and hyperbaric oxygen therapy.
Bollmann PW; Shimada AK; Michalany NS; Manhani AR; Giglio AD
Einstein (Sao Paulo); 2011 Jun; 9(2):212-5. PubMed ID: 26760818
[TBL] [Abstract][Full Text] [Related]
15. Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease.
Reagin H; Marks E; Weis S; Susa J
Am J Dermatopathol; 2018 Sep; 40(9):682-685. PubMed ID: 29533274
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab in the Treatment of Recalcitrant Livedoid Vasculopathy.
Bhatt DM; Bhamburkar S; Madke B; Jangid SD; Khan A
Cureus; 2023 Dec; 15(12):e50053. PubMed ID: 38186477
[TBL] [Abstract][Full Text] [Related]
17. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
[TBL] [Abstract][Full Text] [Related]
18. Livedoid vasculopathy: A review of pathogenesis and principles of management.
Vasudevan B; Neema S; Verma R
Indian J Dermatol Venereol Leprol; 2016; 82(5):478-88. PubMed ID: 27297279
[TBL] [Abstract][Full Text] [Related]
19. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
[TBL] [Abstract][Full Text] [Related]
20. A Case of Livedoid Vasculopathy Successfully Treated with Sulodexide.
Song CH; Shin DS; Jang JW; Kim TL; Kim YG; Kim JS; Seo HM
Ann Dermatol; 2020 Dec; 32(6):508-511. PubMed ID: 33911794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
